These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 19667263)

  • 1. Secondary breast cancer in Hodgkin's lymphoma survivors.
    Crump M; Hodgson D
    J Clin Oncol; 2009 Sep; 27(26):4229-31. PubMed ID: 19667263
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk following irradiation for Hodgkin's disease.
    Clemons M; Loijens L; Goss P
    Cancer Treat Rev; 2000 Aug; 26(4):291-302. PubMed ID: 10913384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast cancer after mantle field irradiation for Hodgkin's disease].
    Katz A; Brenner B; Sulkes A; Luria H; Marshak G; Fenig E
    Harefuah; 2000 May; 138(10):823-5, 911. PubMed ID: 10883245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer in women following mantle irradiation for Hodgkin's disease.
    Peters MH; Sonpal IM; Batra MK
    Am Surg; 1995 Sep; 61(9):763-6. PubMed ID: 7661471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy in Hodgkin disease: why risk a Pyrrhic victory?
    Longo DL
    J Natl Cancer Inst; 2005 Oct; 97(19):1394-5. PubMed ID: 16204683
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma].
    Fosså SD; Holte H; Holmen MM; Bjøro T; Langmark F; Hess SL; Kvaløy S
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):41-4. PubMed ID: 15643464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant breast tumors after radiotherapy for a first cancer during childhood.
    Guibout C; Adjadj E; Rubino C; Shamsaldin A; Grimaud E; Hawkins M; Mathieu MC; Oberlin O; Zucker JM; Panis X; Lagrange JL; Daly-Schveitzer N; Chavaudra J; de Vathaire F
    J Clin Oncol; 2005 Jan; 23(1):197-204. PubMed ID: 15625374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid nodules and survivors of Hodgkin's disease.
    Oeffinger KC; Sklar CA; Hudson MM
    Am Fam Physician; 2003 Sep; 68(6):1016, 1018-9; discussion 1019. PubMed ID: 14524392
    [No Abstract]   [Full Text] [Related]  

  • 10. Creating the basis for a breast health program for female survivors of Hodgkin disease using a participatory research approach.
    Crom DB; Hinds PS; Gattuso JS; Tyc V; Hudson MM
    Oncol Nurs Forum; 2005 Nov; 32(6):1131-41. PubMed ID: 16270109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the risk of second malignant tumors in children with Hodgkin's disease.
    Donaldson SS; O'Brien MM
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):4-5. PubMed ID: 18722256
    [No Abstract]   [Full Text] [Related]  

  • 12. The late effects of mantle field radiotherapy: the information and support needs of women survivors of Hodgkin's disease.
    Grinyer A
    Eur J Oncol Nurs; 2010 Jul; 14(3):183-9. PubMed ID: 20080443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Breast cancer after treatment for Hodgkin's disease].
    Boisselier P; Bretaudeau B
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(4):451. PubMed ID: 7650327
    [No Abstract]   [Full Text] [Related]  

  • 14. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
    Hodgson DC; Koh ES; Tran TH; Heydarian M; Tsang R; Pintilie M; Xu T; Huang L; Sachs RK; Brenner DJ
    Cancer; 2007 Dec; 110(11):2576-86. PubMed ID: 17941006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late complications of therapy of Hodgkin's disease: prevention and management.
    Ng AK; Mauch PM
    Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast cancer after radiotherapy: Risk factors and suggestion for breast delineation as an organ at risk in the prepuberal girl].
    Demoor-Goldschmidt C; Supiot S; Mahé MA
    Cancer Radiother; 2012 Apr; 16(2):140-51. PubMed ID: 22342367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does radiotherapy around the time of pregnancy for Hodgkin's disease modify the risk of breast cancer?
    Chen J; Lee RJ; Tsodikov A; Smith L; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1474-9. PubMed ID: 15050326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast cancer after Hodgkin's disease].
    Cutuli B
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):301-2. PubMed ID: 8767231
    [No Abstract]   [Full Text] [Related]  

  • 19. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
    van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time interval to the development of breast carcinoma after treatment for Hodgkin disease.
    Wendland MM; Tsodikov A; Glenn MJ; Gaffney DK
    Cancer; 2004 Sep; 101(6):1275-82. PubMed ID: 15316904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.